company background image
MRK logo

Merck KGaA XTRA:MRK Stock Report

Last Price

€167.20

Market Cap

€72.7b

7D

8.2%

1Y

0.7%

Updated

20 May, 2024

Data

Company Financials +

MRK Stock Overview

Operates as a science and technology company in Germany.

MRK fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Rewards

Risk Analysis

No risks detected for MRK from our risk checks.

Merck KGaA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Merck KGaA
Historical stock prices
Current Share Price€167.20
52 Week High€172.40
52 Week Low€134.30
Beta0.69
1 Month Change14.52%
3 Month Change9.00%
1 Year Change0.66%
3 Year Change13.86%
5 Year Change85.90%
Change since IPO978.08%

Recent News & Updates

Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20

Apr 26
Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20

Merck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20

Apr 04
Merck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20

Recent updates

Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20

Apr 26
Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20

Merck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20

Apr 04
Merck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20

Merck KGaA (ETR:MRK) Has Affirmed Its Dividend Of €2.20

Mar 18
Merck KGaA (ETR:MRK) Has Affirmed Its Dividend Of €2.20

We Think Merck KGaA (ETR:MRK) Can Stay On Top Of Its Debt

Feb 07
We Think Merck KGaA (ETR:MRK) Can Stay On Top Of Its Debt

There's Reason For Concern Over Merck KGaA's (ETR:MRK) Price

Jan 17
There's Reason For Concern Over Merck KGaA's (ETR:MRK) Price

Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 77% Above Its Share Price

Dec 27
Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 77% Above Its Share Price

Does Merck KGaA (ETR:MRK) Have A Healthy Balance Sheet?

Oct 10
Does Merck KGaA (ETR:MRK) Have A Healthy Balance Sheet?

Is There An Opportunity With Merck KGaA's (ETR:MRK) 49% Undervaluation?

Sep 13
Is There An Opportunity With Merck KGaA's (ETR:MRK) 49% Undervaluation?

Is Merck KGaA (ETR:MRK) A Risky Investment?

Jun 30
Is Merck KGaA (ETR:MRK) A Risky Investment?

Are Investors Undervaluing Merck KGaA (ETR:MRK) By 36%?

Jun 09
Are Investors Undervaluing Merck KGaA (ETR:MRK) By 36%?

These 4 Measures Indicate That MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Using Debt Reasonably Well

Mar 26
These 4 Measures Indicate That MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Using Debt Reasonably Well

MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Dividend Will Be Increased To €2.20

Mar 05
MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Dividend Will Be Increased To €2.20

Estimating The Intrinsic Value Of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK)

Feb 14
Estimating The Intrinsic Value Of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK)

We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Stay On Top Of Its Debt

Dec 12
We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Stay On Top Of Its Debt

Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Trading At A 50% Discount?

Nov 09
Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Trading At A 50% Discount?

Does MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Have A Healthy Balance Sheet?

Aug 15
Does MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Have A Healthy Balance Sheet?

Does MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Have A Healthy Balance Sheet?

May 17
Does MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Have A Healthy Balance Sheet?

MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Dividend Will Be Increased To €1.85

Mar 29
MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Dividend Will Be Increased To €1.85

Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) A Risky Investment?

Jan 13
Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) A Risky Investment?

We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Manage Its Debt With Ease

Oct 15
We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Manage Its Debt With Ease

A Look At The Intrinsic Value Of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK)

Sep 19
A Look At The Intrinsic Value Of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK)

MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Seems To Use Debt Quite Sensibly

Jul 11
MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Seems To Use Debt Quite Sensibly

MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Intrinsic Value Is Potentially 58% Above Its Share Price

Jun 21
MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Intrinsic Value Is Potentially 58% Above Its Share Price

These 4 Measures Indicate That MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Using Debt Reasonably Well

Apr 03
These 4 Measures Indicate That MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Using Debt Reasonably Well

Do Institutions Own MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Shares?

Mar 16
Do Institutions Own MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Shares?

Should Weakness in MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Mar 01
Should Weakness in MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Shareholder Returns

MRKDE PharmaceuticalsDE Market
7D8.2%4.9%-0.5%
1Y0.7%-19.4%4.3%

Return vs Industry: MRK exceeded the German Pharmaceuticals industry which returned -19.4% over the past year.

Return vs Market: MRK underperformed the German Market which returned 4.3% over the past year.

Price Volatility

Is MRK's price volatile compared to industry and market?
MRK volatility
MRK Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement5.0%
10% most volatile stocks in DE Market10.4%
10% least volatile stocks in DE Market2.5%

Stable Share Price: MRK has not had significant price volatility in the past 3 months.

Volatility Over Time: MRK's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
166862,345Belen Garijo Lopezwww.emdgroup.com

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Merck KGaA Fundamentals Summary

How do Merck KGaA's earnings and revenue compare to its market cap?
MRK fundamental statistics
Market cap€72.69b
Earnings (TTM)€2.72b
Revenue (TTM)€20.82b

26.7x

P/E Ratio

3.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MRK income statement (TTM)
Revenue€20.82b
Cost of Revenue€8.70b
Gross Profit€12.12b
Other Expenses€9.40b
Earnings€2.72b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 01, 2024

Earnings per share (EPS)6.26
Gross Margin58.23%
Net Profit Margin13.07%
Debt/Equity Ratio35.5%

How did MRK perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

35%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.